Duesseldorf, March 9, 2017. Gerresheimer, a worldwide leader in primary packaging solutions for the pharmaceutical industry, will enhance its portfolio by adding Gx RTF vials. Ready-to-fill or ready-to-use vials are the state of the art solution to fulfill customer requirements regarding quality, flexibility and less complexity. To achieve this, Gerresheimer and Ompi have signed a mutual agreement in order to allow Gerresheimer to use the Ompi EZ-fill packaging technology. The new products will provide the customers with more flexibility: either with small batches, initially at the clinical trials stage, or with industrial production.
“Our new portfolio will meet the growing demand for comprehensive solutions. Together with Ompi we will make a further step towards establishing one standardized platform for ready-to-fill vials, which make the customer process very easy and smooth,” said Uwe Röhrhoff, CEO of Gerresheimer AG.
“We’re glad our leading technology has been adopted by Gerresheimer. Our solution, which has proved to be scalable, will benefit the customer with more flexibility, increased quality and safety and quicker time to market,” said Mauro Stocchi, General Manager Pharmaceutical Systems division at Stevanato Group.
Vials are the standard primary packaging for parenteral drugs. Gerresheimer offers vials in all sizes corresponding to international standards and pharmacopoeia requirements. The Gerresheimer offering does include solutions for biotech and other specialist pharma drugs. The new Gx RTF vial portfolio will be based on already established quality offerings for vials like PharmaPlus and Elite Glass. By adapting this knowledge to vials and combining it with the well-established Ompi EZ-fill packaging solution provides added value to customers, enabling them to source one identically packed vial from two suppliers.
Ready-to-fill vials are washed and sterilized solutions provided in trays or in nests and tubs. The pharmaceutical customer can immediately fill the ready-to-fill vials without any further process. Gerresheimer has been producing RTF glass syringes (ready to fill) for more than 15 years already and has recently launched RTF COP syringes produced in Europe.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With plants in Europe, North America, South America and Asia, Gerresheimer generates revenues of around EUR 1.4bn. The company’s comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
Gx® and RTF® are registered trademarks of the Gerresheimer Group.
Ompi EZ-fill® is a registered trademark of Ompi, a Stevanato Group Brand.
Founded in 1949, Stevanato Group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. It comprises two operational divisions dedicated to serve the pharmaceutical industry: Pharmaceutical Systems with Ompi specialized in glass primary packaging and Balda, focused on specialty plastics and delivery devices; Engineering Systems with Spami, Optrel, InnoScan and SVM, specialized in glass processing, inspection systems, assembly and packaging solutions.
With operations in Italy, Slovakia, Mexico and China, Ompi offers the widest range of glass primary packaging, from the traditional ones such as vials and ampoules, to the high value ones as syringes and cartridges for auto-injectors and pen-injectors. Vials, cartridges and syringes are available also sterile and ready to fill (Ompi EZ-fill®).